Abstract
The idiopathic interstitial pneumonias (IIPs) comprise a number of clinico-pathological entities of unknown origin, which are sufficiently different from one another to be designated as separate disease entities. The aim of this review is to describe the level of evidence available on the efficacy of corticosteroids and immunosuppressive, antifibrotic, or immunomodulatory therapies in the treatment of different IIPs.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use*
-
Bronchiolitis Obliterans / diagnosis*
-
Bronchiolitis Obliterans / drug therapy*
-
Bronchiolitis Obliterans / mortality
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Lung Diseases, Interstitial / diagnosis
-
Lung Diseases, Interstitial / drug therapy
-
Lung Diseases, Interstitial / mortality
-
Male
-
Prognosis
-
Pulmonary Fibrosis / diagnosis*
-
Pulmonary Fibrosis / drug therapy*
-
Pulmonary Fibrosis / mortality
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Severity of Illness Index
-
Survival Rate
-
Treatment Outcome
Substances
-
Adrenal Cortex Hormones
-
Immunosuppressive Agents